Fulcrum Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 02/09/2026 | Mar 2026Filed 02/09/2026 | Sep 2025Filed 29/10/2025 | Jun 2025Filed 02/09/2026 | Mar 2025Filed 02/09/2026 | Sep 2024Filed 29/10/2025 | Jun 2024Filed 29/10/2025 | Mar 2024Filed 29/10/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | $0 | $0 | — | $0 | $80 | $0 | |
| −$26 | −$19 | −$20 | −$17 | −$18 | −$22 | $55 | −$27 | |
| −$0.34 | −$0.25 | −$0.31 | −$0.28 | −$0.28 | −$0.35 | $0.87 | −$0.43 | |
| 76 | 76 | 63 | 63 | 62 | 62 | 64 | 62 |
Trend